According to Intel Market Research, the global Pembrolizumab market is projected to grow from USD 21.8 billion in 2025 to USD 42.7 billion by 2034, registering a CAGR of 7.3%. Market expansion is driven by increasing cancer prevalence, expanding FDA approvals across multiple indications, rising immunotherapy adoption, and strategic clinical trial expansions by Merck & Co., Inc.
Read MoreData Bridge Market Research analyzes that the Middle East and Africa biological buffers market is expected to reach USD 50.41 million by 2035 from USD 28.79 million in 2024, growing at a substantial CAGR of 5.3% in the forecast period of 2025 to 2035.
Read MoreThe global surgical, medical, and hospital instruments market size was valued at USD 48.20 billion in 2024 and is expected to reach USD 85.32 billion by 2032, at a CAGR of 6.80% during the forecast period.
Read MoreThe global balloon-expandable stents market size was valued at USD 3.10 billion in 2024 and is projected to reach USD 5.75 billion by 2032, with a CAGR of 8.04% during the forecast period of 2025 to 2032.
Read MoreGlobal biomedical refrigerators and freezers market size was valued at USD 4.92 billion in 2024 and is projected to reach USD 9.82 billion by 2032, with a CAGR of 9.01% during the forecast period of 2025 to 2032.
Read More